Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pharmaniaga Bhd's Enterprise Value is RM2,155 Mil.
Pharmaniaga Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was RM130 Mil. Therefore, Pharmaniaga Bhd's EV-to-EBIT ratio for today is 16.60.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Pharmaniaga Bhd's Enterprise Value is RM2,155 Mil.
Pharmaniaga Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was RM130 Mil. Therefore, Pharmaniaga Bhd's EV-to-EBITDA ratio for today is 16.60.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Pharmaniaga Bhd's Enterprise Value is RM2,155 Mil.
Pharmaniaga Bhd's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was RM4,051 Mil. Therefore, Pharmaniaga Bhd's EV-to-Revenue ratio for today is 0.53.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Pharmaniaga Bhd's Enterprise Value is RM2,155 Mil.
Pharmaniaga Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was RM-99 Mil. Therefore, Pharmaniaga Bhd's EV-to-FCF ratio for today is -21.76.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Pharmaniaga Bhd (XKLS:7081) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Pharmaniaga Bhd's current Enterprise Value is RM2,155 Mil.
Pharmaniaga Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM130 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Pharmaniaga Bhd's current Enterprise Value is RM2,155 Mil.
Pharmaniaga Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM130 Mil.
Pharmaniaga Bhd's current Enterprise Value is RM2,155 Mil.
Pharmaniaga Bhd's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM4,051 Mil.
Pharmaniaga Bhd's current Enterprise Value is RM2,155 Mil.
Pharmaniaga Bhd's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-61 Mil.
Pharmaniaga Bhd's current Enterprise Value is RM2,155 Mil.
Pharmaniaga Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd Enterprise Value Related Terms
Pharmaniaga Bhd Enterprise Value Historical Data
* Premium members only.
The historical data trend for Pharmaniaga Bhd's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7081 vs MCK, CAH, COR: Enterprise Value Comparison
For the Medical Distribution subindustry, Pharmaniaga Bhd's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Pharmaniaga Bhd's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a Enterprise Value of RM2,155 Mil as of Jul. 18, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pharmaniaga Bhd and its competitors.
Is Pharmaniaga Bhd's Enterprise Value too high?
Pharmaniaga Bhd's current Enterprise Value is RM2,155 Mil. Overall, Pharmaniaga Bhd has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Enterprise Value compare to MCK and CAH?
Pharmaniaga Bhd's Enterprise Value of RM2,155 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pharmaniaga Bhd and its competitors. Pharmaniaga Bhd's current Enterprise Value is RM2,155 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.73, compared to a current price of RM1.18 — trading 61.6% above its estimated fair value. The current Enterprise Value is RM2,155 Mil. Pharmaniaga Bhd's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Enterprise Value is RM2,155 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.18 is trading 61.6% above its estimated GF Value™ of RM0.73.
GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:7081:
Enterprise Value: RM2,155 Mil
GF Value™: RM0.73 vs. price of RM1.18 (61.6% above fair value)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
45GF Score
Get the complete analysis for XKLS:7081
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
